AAD 2026Abstract 73233Clinical trial
Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide
Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials
Soung J, Armstrong AW, Vender RB, Riera-Monroig J, Sebastian M, Reyes-Servin O, Edem BE, Hsu MC, Li S, Yang YW, Gold LS
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1817 · Not in PubMed: details from Crossref